Dermatology Research and Practice / 2018 / Article / Fig 1

Research Article

Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients

Figure 1

Scatter dot plot diagram of IL-27 serum levels; the middle line represents the median levels of serum IL-27. The ends of the whiskers represent 10-90 percentile; outliers are plotted as individual points; SCC: Squamous Cell Carcinoma; BCC: Basal Cell Carcinoma; NMSC: nonmelanoma skin cancer (SCC+BCC); IL-27 serum levels were significantly higher in NMSC, SCC, and BCC patients in comparison to controls (0.0134, 0.0134, and 0.0100 ng/ml respectively versus 0.0008 ng/ml).